Abstract
The extended use of doxorubicin (DOX) could be limited due to the emergence of drug resistance and cardiotoxicity associated with its treatment. Conjugates of DOX with transferrin (DOX–TRF) can effectively alleviate these side effects, thereby leading to a better treatment. The effectiveness of DOX–TRF could result from the enhancement of transferrin receptor (TfR)-mediated transportation. However, detailed TfR-mediated DOX delivery has not been fully elucidated thus far, which may rely on the quantitative subcellular study of DOX distribution and metabolism. In this study, an immunoisolation assay was developed to isolate the organelles with high purity, yield and integrity. Using this immunoisolation assay together with liquid chromatography–tandem mass spectrometry (LC/MS/MS), the subcellular distribution profiles of DOX and its main metabolite doxorubicinol (DOXol) in human breast cancer cells MCF-7/WT and MCF-7/ADR were determined and compared after the treatment of DOX and DOX–TRF. As expected, DOX–TRF treated cells have a higher drug accumulation compared to DOX treated cells. DOX–TRF was predominantly cytoplasmic. In addition, TfR-mediated transportation had a significant impact on the transformation of DOX to DOXol in the cells. This study provided the evidence that immunoisolation together with LC/MS/MS is an effective technique in subcellular investigations.
Similar content being viewed by others
References
Akhtar N, Ahad A, Khar RK, Jaggi M, Aqil M, Iqbal Z, Ahmad FJ, Talegaonkar S (2012) The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review. Expert Opin Ther Pat 21:561–576
Altan N, Chen Y, Schindler M, Simon SM (1998) Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 187:1583–1598
Anderson RG, Falck JR, Goldstein JL, Brown MS (1984) Visualization of acidic organelles in intact cells by electron microscopy. Proc Natl Acad Sci USA 81:4838–4842
Berczi A, Barabas K, Sizensky JA, Faulk WP (1993) Adriamycin conjugates of human transferrin bind transferrin receptors and kill K562 and HL60 cells. Arch Biochem Biophys 300:356–363
Bidwell GL 3rd, Davis AN, Fokt I, Priebe W, Raucher D (2007) A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Invest New Drugs 25:313–326
Boonstra J, Verkleij AJ (2004) Regulation of enzyme activity in vivo is determined by its cellular localization. Adv Enzyme Regul 44:61–73
Booser DJ, Hortobagyi GN (1994) Anthracycline antibiotics in cancer therapy. Focus on drug resistance. Drugs 47:223–258
Chang PS, Absood A, Linderman JJ, Omann GM (2004) Magnetic bead isolation of neutrophil plasma membranes and quantification of membrane-associated guanine nucleotide binding proteins. Anal Biochem 325:175–184
Dri P, Presani G, Perticarari S, Alberi L, Prodan M, Decleva E (2002) Measurement of phagosomal pH of normal and CGD-like human neutrophils by dual fluorescence flow cytometry. Cytometry 48:159–166
Dubowchik GM, Padilla L, Edinger K, Firestone RA (1994) Reversal of doxorubicin resistance and catalytic neutralization of lysosomes by a lipophilic imidazole. Biochim Biophys Acta 1191:103–108
Eder AR, Arriaga EA (2005) Micellar electrokinetic capillary chromatography reveals differences in intracellular metabolism between liposomal and free doxorubicin treatment of human leukemia cells. J Chromatogr B Analyt Technol Biomed Life Sci 829:115–122
Elliott RL, Elliott MC, Wang F, Head JF (1993) Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study. Ann N Y Acad Sci 698:159–166
Eskelinen E, Tanaka Y, Saftig P (2003) At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 13:137–144
Flukiger-Gagescu R, Gruenberg J (2006) Immunoisolation of organelles using magnetic solid supports. Academic Press, San Diego
Fritzer M, Szekeres T, Szuts V, Jarayam HN, Goldenberg H (1996) Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells. Biochem Pharmacol 51:489–493
Fusek M, Vetvicka V (2005) Dual role of cathepsin D: ligand and protease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149:43–50
Gaudiano G, Koch TH, Lo Bello M, Nuccetelli M, Ravagnan G, Serafino A, Sinibaldi-Vallebona P (2000) Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines. Biochem Pharmacol 60:1915–1923
Grab DJ, Webster P, Lonsdale-Eccles JD (1998) Analysis of trypanosomal endocytic organelles using preparative free-flow electrophoresis. Electrophoresis 19:1162–1170
Grimshaw CE, Bohren KM, Lai CJ, Gabbay KH (1995) Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. Biochemistry 34:14356–14365
Harford JB, Bonifacino JS (2010) Subcellular fractionation and isolation of organelles. In: Current Protocols in Cell Biology. Wiley
Herrnstadt C, Clevenger W, Ghosh SS, Anderson C, Fahy E, Miller S, Howell N, Davis RE (1999) A novel mitochondrial DNA-like sequence in the human nuclear genome. Genomics 60:67–77
Hornig-Do HT, Gunther G, Bust M, Lehnartz P, Bosio A, Wiesner RJ (2009) Isolation of functional pure mitochondria by superparamagnetic microbeads. Anal Biochem 389:1–5
Hortobagyi GN (1997) Anthracyclines in the treatment of cancer: an overview. Drugs 54:1–7
Huebers HA, Finch CA (1987) The physiology of transferrin and transferrin receptors. Physiol Rev 67:520–582
Kharasch ED, Novak RF (1983) Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclines. Arch Biochem Biophys 224:682–694
Kiri AN, Tran HC, Drahos KL, Lan W, McRorie DK, Horn MJ (2005) Proteomic changes in bovine heart mitochondria with age: using a novel technique for organelle separation and enrichment. J Biomol Tech 16:371–379
Kratz F, Beyer U, Roth T, Tarasova N, Collery P, Lechenault F, Cazabat A, Schumacher P, Unger C, Falken U (1998) Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy. J Pharm Sci 87:338–346
Lawen A, Ly JD, Lane DJ, Zarschler K, Messina A, De Pinto V (2005) Voltage-dependent anion-selective channel 1 (VDAC1)—a mitochondrial protein, rediscovered as a novel enzyme in the plasma membrane. Int J Biochem Cell Biol 37:277–282
Lee SA, Karaszkiewicz JW, Anderson WB (1992) Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res 52:3750–3759
Leighton F, Poole B, Beaufay H, Baudhuin P, Coffey JW, Fowler S, De Duve C (1968) The large-scale separation of peroxisomes, mitochondria, and lysosomes from the livers of rats injected with triton WR-1339. Improved isolation procedures, automated analysis, biochemical and morphological properties of fractions. J Cell Biol 37:482–513
Li H, Qian ZM (2002) Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 22:225–250
Lubgan D, Jozwiak Z, Grabenbauer GG, Distel LV (2009) Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells. Cell Mol Biol Lett 14:113–127
Mealey KL, Barhoumi R, Burghardt RC, Safe S, Kochevar DT (2002) Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells. Antimicrob Agents Chemother 46:755–761
Meszaros E, Malemud CJ (2012) Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity. Ther Adv Chronic Dis 3:219–229
Mpoke SS, Wolfe J (1997) Differential staining of apoptotic nuclei in living cells: application to macronuclear elimination in Tetrahymena. J Histochem Cytochem 45:675–683
Mura CV, Becker MI, Orellana A, Wolff D (2002) Immunopurification of Golgi vesicles by magnetic sorting. J Immunol Methods 260:263–271
Niessen J, Jedlitschky G, Grube M, Bien S, Strobel U, Ritter CA, Greinacher A, Kroemer HK (2007) Subfractionation and purification of intracellular granule-structures of human platelets: an improved method based on magnetic sorting. J Immunol Methods 328:89–96
Nilsson C, Kagedal K, Johansson U, Ollinger K (2003) Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry. Methods Cell Sci 25:185–194
Pasquali C, Fialka I, Huber LA (1999) Subcellular fractionation, electromigration analysis and mapping of organelles. J Chromatogr B Biomed Sci Appl 722:89–102
Qian ZM, Li H, Sun H, Ho K (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54:561–587
Sacco G, Giampietro R, Salvatorelli E, Menna P, Bertani N, Graiani G, Animati F, Goso C, Maggi CA, Manzini S, Minotti G (2003) Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity. Br J Pharmacol 139:641–651
Schroter CJ, Braun M, Englert J, Beck H, Schmid H, Kalbacher H (1999) A rapid method to separate endosomes from lysosomal contents using differential centrifugation and hypotonic lysis of lysosomes. J Immunol Methods 227:161–168
Shen F, Chu S, Bence AK, Bailey B, Xue X, Erickson PA, Montrose MH, Beck WT, Erickson LC (2008) Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J Pharmacol Exp Ther 324:95–102
Sims NR, Anderson MF (2008) Isolation of mitochondria from rat brain using Percoll density gradient centrifugation. Nat Protoc 3:1228–1239
Singh M (1999) Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Design 5:443–451
Stefanelli C, Stanic I, Zini M, Bonavita F, Flamigni F, Zambonin L, Landi L, Pignatti C, Guarnieri C, Caldarera CM (2000) Polyamines directly induce release of cytochrome c from heart mitochondria. Biochem J 347(Pt 3):875–880
Stroikin Y, Mild H, Johansson U, Roberg K, Ollinger K (2008) Lysosome-targeted stress reveals increased stability of lipofuscin-containing lysosomes. Age (Dordr) 30:31–42
Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ, Trent JM (1991) Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 63:923–929
van Renswoude J, Bridges KR, Harford JB, Klausner RD (1982) Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc Natl Acad Sci USA 79:6186–6190
Vartdal F (1988) Use of antibody-coated magnetic particles for specific isolation of living cells. Fresenius J Anal Chem 330:328–329
Wallace KB (2003) Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol 93:105–115
Wang F, Jiang X, Yang DC, Elliott RL, Head JF (2000) Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells. Anticancer Res 20:799–808
Xu J, Liu Y, Yu Y, Ni Q, Chen Y (2012) Subcellular quantification of doxorubicin and its metabolite in cultured human leukemia cells using liquid chromatography-tandem mass spectrometry. Anal Lett 45:1980–1994
Yeh CJ, Faulk WP (1984) Killing of human tumor cells in culture with adriamycin conjugates of human transferrin. Clin Immunol Immunopathol 32:1–11
Zucker RM, Hunter ES 3rd, Rogers JM (1999) Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods 18:473–480
Acknowledgments
National natural science fund (20905037), Jiangsu natural science fund (BK2009419) and Research fund for the doctoral program of higher education of China (20093234120010) to Dr. Chen is gratefully acknowledged. The authors would also like to thank American Journal Experts for proofreading the article.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xu, J., Sheng, Y., Xu, F. et al. Quantitative subcellular study of transferrin receptor-targeted doxorubicin and its metabolite in human breast cancer cells. Eur J Drug Metab Pharmacokinet 39, 301–310 (2014). https://doi.org/10.1007/s13318-013-0165-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13318-013-0165-6